Yongning Jia

1.4k total citations
56 papers, 834 citations indexed

About

Yongning Jia is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Yongning Jia has authored 56 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 21 papers in Gastroenterology and 18 papers in Surgery. Recurrent topics in Yongning Jia's work include Gastric Cancer Management and Outcomes (36 papers), Gastrointestinal Tumor Research and Treatment (21 papers) and Metastasis and carcinoma case studies (20 papers). Yongning Jia is often cited by papers focused on Gastric Cancer Management and Outcomes (36 papers), Gastrointestinal Tumor Research and Treatment (21 papers) and Metastasis and carcinoma case studies (20 papers). Yongning Jia collaborates with scholars based in China, Ethiopia and United Kingdom. Yongning Jia's co-authors include Jiafu Ji, Ziyu Li, Fei Shan, Shuangxi Li, Wen G. Jiang, Lianhai Zhang, Kan Xue, Ke Ji, Lin Ye and Yinkui Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yongning Jia

53 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongning Jia China 16 395 286 267 201 153 56 834
Zuli Yang China 18 297 0.8× 442 1.5× 290 1.1× 176 0.9× 130 0.8× 44 963
Jirong Huo China 19 228 0.6× 566 2.0× 147 0.6× 310 1.5× 265 1.7× 56 1.0k
Tsuneaki Fujiya Japan 16 387 1.0× 342 1.2× 235 0.9× 305 1.5× 136 0.9× 37 954
Dan Sun China 14 214 0.5× 323 1.1× 209 0.8× 140 0.7× 60 0.4× 27 709
Reiko Masunaga Japan 14 496 1.3× 223 0.8× 259 1.0× 441 2.2× 92 0.6× 20 1.0k
Wiesław Janusz Kruszewski Poland 13 215 0.5× 164 0.6× 234 0.9× 146 0.7× 122 0.8× 49 672
Kazuho Imanaka Japan 14 306 0.8× 134 0.5× 171 0.6× 242 1.2× 113 0.7× 29 901
Liqiao Fan China 20 205 0.5× 585 2.0× 170 0.6× 129 0.6× 63 0.4× 71 965
Bastiaan P. van Rees Netherlands 15 243 0.6× 171 0.6× 264 1.0× 467 2.3× 55 0.4× 20 949
Ling Gao United States 15 317 0.8× 207 0.7× 343 1.3× 105 0.5× 77 0.5× 46 633

Countries citing papers authored by Yongning Jia

Since Specialization
Citations

This map shows the geographic impact of Yongning Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongning Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongning Jia more than expected).

Fields of papers citing papers by Yongning Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongning Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongning Jia. The network helps show where Yongning Jia may publish in the future.

Co-authorship network of co-authors of Yongning Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Yongning Jia. A scholar is included among the top collaborators of Yongning Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongning Jia. Yongning Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2025). Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forests. European Journal of Surgical Oncology. 51(8). 109752–109752.
3.
Cheng, Xiaojing, Yongning Jia, Xiaohuan Tang, et al.. (2024). ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer. Clinical and Translational Medicine. 14(8). e1754–e1754. 12 indexed citations
6.
Ruge, Fiona, Ke Ji, Shuqin Jia, et al.. (2023). ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient’s Response to Chemotherapies. Anticancer Research. 43(4). 1463–1475. 4 indexed citations
7.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2023). Efficacy and safety of preoperative immunotherapy alone followed by surgery in the treatment of advanced gastric cancer with MSI-H/dMMR or EBV-positive. Journal of the Chinese Medical Association. 86(8). 717–724. 7 indexed citations
8.
Shan, Fei, Shuangxi Li, Yongning Jia, et al.. (2022). The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer. Frontiers in Oncology. 12. 956706–956706. 1 indexed citations
9.
Xing, Xiaofang, Jinyao Shi, Yongning Jia, et al.. (2022). Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis. Journal for ImmunoTherapy of Cancer. 10(3). e003984–e003984. 40 indexed citations
10.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2022). Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials. World Journal of Surgical Oncology. 20(1). 405–405. 12 indexed citations
11.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2021). Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer. European Journal of Surgical Oncology. 47(8). 2023–2030. 11 indexed citations
12.
Liu, Zining, Yinkui Wang, Fei Shan, et al.. (2021). Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved. Frontiers in Oncology. 11. 775166–775166. 3 indexed citations
13.
Li, Ziyu, Yongning Jia, Honglin Zhu, et al.. (2021). Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy. Gastric Cancer. 24(6). 1342–1354. 21 indexed citations
15.
Jia, Yongning, Ke Ji, Jiafu Ji, et al.. (2016). IL24 and its Receptors Regulate Growth and Migration of Pancreatic Cancer Cells and Are Potential Biomarkers for IL24 Molecular Therapy.. PubMed. 36(3). 1153–63. 9 indexed citations
16.
Ye, Lin, Yongning Jia, Ke Ji, et al.. (2015). Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis. Oncology Letters. 10(3). 1240–1250. 124 indexed citations
17.
Ji, Jiafu, Shuqin Jia, Yongning Jia, et al.. (2015). WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways. British Journal of Cancer. 113(6). 921–933. 28 indexed citations
18.
Wu, Aiwen, Yongning Jia, Bin Dong, et al.. (2014). Apoptosis and KI 67 index correlate with preoperative chemotherapy efficacy and better predict the survival of gastric cancer patients with combined therapy. Cancer Chemotherapy and Pharmacology. 73(5). 885–893. 17 indexed citations
19.
Xing, Xiaofang, Shenyi Lian, Ying Hu, et al.. (2013). Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. Journal of Translational Medicine. 11(1). 309–309. 25 indexed citations
20.
Du, Yunxia, Lianhai Zhang, Xiaojing Cheng, et al.. (2012). 03. Expression of CEBPB in human gastric carcinoma and its clinical significance. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026